test s microarray images Search Results


93
SCIENION test s microarray images
Test S Microarray Images, supplied by SCIENION, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/sciREADER+CL2/pmc11053182-66-1-16
Average 93 stars, based on 1 article reviews
test s microarray images - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
BioNano Genomics genome imaging analysis
Genome Imaging Analysis, supplied by BioNano Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/genome+imaging/pm33262485-18591-20-21
Average 90 stars, based on 1 article reviews
genome imaging analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
JENOPTIK Inc jenoptik camera
Jenoptik Camera, supplied by JENOPTIK Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/jenoptik+camera/pmc07118981-54-11-11
Average 90 stars, based on 1 article reviews
jenoptik camera - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MetaSystems inc isis software
Isis Software, supplied by MetaSystems inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/isis+software/pmc07441545-70-16-18
Average 90 stars, based on 1 article reviews
isis software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare indirect calorimetry
Indirect Calorimetry, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/indirect+calorimetry/10__1172_slash_jci148798-386-25-5
Average 90 stars, based on 1 article reviews
indirect calorimetry - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Alpha Innotech accepted macroimaging systems fluorchem alphaimager redtm alphadigidoc large scale imaging
Accepted Macroimaging Systems Fluorchem Alphaimager Redtm Alphadigidoc Large Scale Imaging, supplied by Alpha Innotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/alphadigidoc+imaging+pro+system/sec_filing____830736_slash_000119312508088054_slash_dex991-188-3-0
Average 86 stars, based on 1 article reviews
accepted macroimaging systems fluorchem alphaimager redtm alphadigidoc large scale imaging - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Alpha Innotech solutions software
Solutions Software, supplied by Alpha Innotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/software+solutions/sec_filing____830736_slash_000119312508088054_slash_dex991-205-6-0
Average 86 stars, based on 1 article reviews
solutions software - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
PrimerDesign Inc primer3 version 4.1.0
Primer3 Version 4.1.0, supplied by PrimerDesign Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/primer3/pmc07286919__41467_2020_16758_MOESM2_ESM-9-61-66
Average 90 stars, based on 1 article reviews
primer3 version 4.1.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Broad Institute Inc integrative genomics viewer version 2.4.9
Integrative Genomics Viewer Version 2.4.9, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/integrative+genomics+viewer/pmc07286919__41467_2020_16758_MOESM2_ESM-9-68-73
Average 90 stars, based on 1 article reviews
integrative genomics viewer version 2.4.9 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioFire Defense filmarray® blood cultures identification 2 (bcid2
Filmarray® Blood Cultures Identification 2 (Bcid2, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/bcid2+panel/pm37738671-104-107-114
Average 90 stars, based on 1 article reviews
filmarray® blood cultures identification 2 (bcid2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenMark Diagnostics eplex® (genmark diagnostics, inc)
Eplex® (Genmark Diagnostics, Inc), supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/genmark+eplex/pm37738671-104-179-180
Average 90 stars, based on 1 article reviews
eplex® (genmark diagnostics, inc) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CH Instruments hmga1 expression
<t>HMGA1</t> enhanced oncogenic progression of pCCA cells. a Left: Heatmap of HMG gene expression profiles in eight pairs of pCCA tissues and adjacent normal tissues. Right: FPKM of HMGA1 in pCCA and adjacent normal tissues were shown. Data were were analyzed by paired t tests ( b ) HMGA1 mRNA expression in 18 paired pCCA and adjacent normal duct tissues, detected by qRT-PCR. P value was calculated with paired t tests. c Up: HMGA1 expression in four randomly-selected pairs of pCCA tissues (T) and adjacent normal tissues (N), detected by Western blot. Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ). * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with the corresponding control group. Data are shown as means ±S.D., and statistical significance was analyzed with one-way ANOVA( h and k ) or T-test. Analyzed data were from three independent experiments, and each subgroup was performed at least in triplicate ( c , g , h , i , l - p )
Hmga1 Expression, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+s+microarray+images/chi+square/pmc07923631-134-71-45
Average 90 stars, based on 1 article reviews
hmga1 expression - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


HMGA1 enhanced oncogenic progression of pCCA cells. a Left: Heatmap of HMG gene expression profiles in eight pairs of pCCA tissues and adjacent normal tissues. Right: FPKM of HMGA1 in pCCA and adjacent normal tissues were shown. Data were were analyzed by paired t tests ( b ) HMGA1 mRNA expression in 18 paired pCCA and adjacent normal duct tissues, detected by qRT-PCR. P value was calculated with paired t tests. c Up: HMGA1 expression in four randomly-selected pairs of pCCA tissues (T) and adjacent normal tissues (N), detected by Western blot. Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ). * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with the corresponding control group. Data are shown as means ±S.D., and statistical significance was analyzed with one-way ANOVA( h and k ) or T-test. Analyzed data were from three independent experiments, and each subgroup was performed at least in triplicate ( c , g , h , i , l - p )

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc

doi: 10.1186/s13046-021-01890-1

Figure Lengend Snippet: HMGA1 enhanced oncogenic progression of pCCA cells. a Left: Heatmap of HMG gene expression profiles in eight pairs of pCCA tissues and adjacent normal tissues. Right: FPKM of HMGA1 in pCCA and adjacent normal tissues were shown. Data were were analyzed by paired t tests ( b ) HMGA1 mRNA expression in 18 paired pCCA and adjacent normal duct tissues, detected by qRT-PCR. P value was calculated with paired t tests. c Up: HMGA1 expression in four randomly-selected pairs of pCCA tissues (T) and adjacent normal tissues (N), detected by Western blot. Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ). * P < 0.05, ** P < 0.01, and *** P < 0.001 compared with the corresponding control group. Data are shown as means ±S.D., and statistical significance was analyzed with one-way ANOVA( h and k ) or T-test. Analyzed data were from three independent experiments, and each subgroup was performed at least in triplicate ( c , g , h , i , l - p )

Article Snippet: Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ).

Techniques: Gene Expression, Expressing, Quantitative RT-PCR, Western Blot, Immunohistochemical staining, Staining, Microarray, CCK-8 Assay, Knockdown, Over Expression, Injection, Infection, shRNA, Plasmid Preparation, Migration, Wound Healing Assay, Transwell Assay, Activity Assay, Control

HMGA1 promoted the transcription and expression of TRIP13 . a Heatmap and hierarchical clustering analysis revealed 180 up-regulated gene expression profiles in eight pairs of pCCA tissues and adjacent normal tissues. TRIP13 was filtered out as the only overlapping gene between the 21 Proteomic HMGA1-linked signature and 180 total upregulated genes ( a ). c Correlations between HMGA1 and LRRC59/KIFC1/TRIP13 mRNA in 36 cases of CCA were evaluated. The linear correlations were analyzed using the Spearman method. d Changes in LRRC59 / KIFC1 / TRIP13 mRNA after knocking down or overexpressing HMGB1 in QBC939 cells. e Correlation between HMGA1 and TRIP13 mRNA in 12 fresh pCCA tissues. mRNA ratio was calculated by mRNA (tumor)/mRNA (adjacent tissue). f Representative IHC images of low and high TRIP13 expression (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). g IHC scores of HMGA1 were significantly associated with TRIP13 scores in pCCA tissues. h Patients with high HMGA1 expression had higher TRIP13 expression. i TRIP13 expression was detected in stable QBC939 cells with HMGA1 knockdown or overexpression. j and k HMGA1 promoted the transcription of TRIP13 in both QBC939 and FRH0201 cells ( j ), and 293 T cells( k ). The transcriptional activity of TRIP13 was detected with luciferase assays. * represented P < 0.05, and *** represented P < 0.001 compared with control or indicated groups, calculated by T-test in ( j , h and k ). Spearman correlation analysis was performed in ( c , e and g ). Analyzed data were from three independent experiments, and shown as means± SEM

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc

doi: 10.1186/s13046-021-01890-1

Figure Lengend Snippet: HMGA1 promoted the transcription and expression of TRIP13 . a Heatmap and hierarchical clustering analysis revealed 180 up-regulated gene expression profiles in eight pairs of pCCA tissues and adjacent normal tissues. TRIP13 was filtered out as the only overlapping gene between the 21 Proteomic HMGA1-linked signature and 180 total upregulated genes ( a ). c Correlations between HMGA1 and LRRC59/KIFC1/TRIP13 mRNA in 36 cases of CCA were evaluated. The linear correlations were analyzed using the Spearman method. d Changes in LRRC59 / KIFC1 / TRIP13 mRNA after knocking down or overexpressing HMGB1 in QBC939 cells. e Correlation between HMGA1 and TRIP13 mRNA in 12 fresh pCCA tissues. mRNA ratio was calculated by mRNA (tumor)/mRNA (adjacent tissue). f Representative IHC images of low and high TRIP13 expression (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). g IHC scores of HMGA1 were significantly associated with TRIP13 scores in pCCA tissues. h Patients with high HMGA1 expression had higher TRIP13 expression. i TRIP13 expression was detected in stable QBC939 cells with HMGA1 knockdown or overexpression. j and k HMGA1 promoted the transcription of TRIP13 in both QBC939 and FRH0201 cells ( j ), and 293 T cells( k ). The transcriptional activity of TRIP13 was detected with luciferase assays. * represented P < 0.05, and *** represented P < 0.001 compared with control or indicated groups, calculated by T-test in ( j , h and k ). Spearman correlation analysis was performed in ( c , e and g ). Analyzed data were from three independent experiments, and shown as means± SEM

Article Snippet: Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ).

Techniques: Expressing, Gene Expression, Knockdown, Over Expression, Activity Assay, Luciferase, Control

TRIP13 was required for HMGA1-induced pCCA progression. a , b CCK8 assay ( a ) and colony formation assay ( b ) showed that TRIP13 knockdown attenuated the proliferation induced by HMGA1 overexpression. c Stable QBC-939 cells with/without HMGA1 overexpression and TIRP13 knockdown were injected subcutaneously for xenografts. d TIRP13 knockdown significantly decreased the volume and weight of xenografts. e , f TIRP13 knockdown attenuated cell ability of migration( e ) and invasion( f ) of pCCA cells. g TRIP13 is required in HMGA1-induced metastasis. Up: metastasis of stable QBC-939 cells with TIRP13 knockdown and/or HMGA1 overexpression to the liver, as verified by HE staining. The mouse metastasis model was established by tail vein injection of stable cells. Scale bar: 50 μm. h numbers of metastatic lesions on the surface of the liver. i 7-day sphere formation assays were performed to evaluated the effects of TRIP13 on HMGA1-induced pCCA stemness. j EMT biomarkers were detected to evaluate the effects of TRIP13 on HMGA1-induced pCCA EMT. n.s. represents not significant. *, ** and *** represents P < 0.05, P < 0.01 and P < 0.001, analyzed with one-way ANOVA( a , d ) or T-test ( b , e , f , i , h , j ). Analyzed data were from three independent experiments, and each subgroup was performed at least in triplicate ( a , b , e , f , i , j )

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc

doi: 10.1186/s13046-021-01890-1

Figure Lengend Snippet: TRIP13 was required for HMGA1-induced pCCA progression. a , b CCK8 assay ( a ) and colony formation assay ( b ) showed that TRIP13 knockdown attenuated the proliferation induced by HMGA1 overexpression. c Stable QBC-939 cells with/without HMGA1 overexpression and TIRP13 knockdown were injected subcutaneously for xenografts. d TIRP13 knockdown significantly decreased the volume and weight of xenografts. e , f TIRP13 knockdown attenuated cell ability of migration( e ) and invasion( f ) of pCCA cells. g TRIP13 is required in HMGA1-induced metastasis. Up: metastasis of stable QBC-939 cells with TIRP13 knockdown and/or HMGA1 overexpression to the liver, as verified by HE staining. The mouse metastasis model was established by tail vein injection of stable cells. Scale bar: 50 μm. h numbers of metastatic lesions on the surface of the liver. i 7-day sphere formation assays were performed to evaluated the effects of TRIP13 on HMGA1-induced pCCA stemness. j EMT biomarkers were detected to evaluate the effects of TRIP13 on HMGA1-induced pCCA EMT. n.s. represents not significant. *, ** and *** represents P < 0.05, P < 0.01 and P < 0.001, analyzed with one-way ANOVA( a , d ) or T-test ( b , e , f , i , h , j ). Analyzed data were from three independent experiments, and each subgroup was performed at least in triplicate ( a , b , e , f , i , j )

Article Snippet: Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ).

Techniques: CCK-8 Assay, Colony Assay, Knockdown, Over Expression, Injection, Migration, Staining

HMGA1-TRIP13 axis promotes invasion, stemness and EMT in a positive feedback pathway dependent on c-Myc. a , b WB( a ) and qRT-PCR( b ) showed that FBXW7 and TRIP13 knockdown regulated c-Myc expression but had little effect on c-Myc mRNA. c MG132 inhibited the FBXW7-induced c-Myc degradation. QBC-939(left) and FRH-0201(right) were incubated in 10 μM MG132 for 12 h before lysis. d FBXW7 knockdown decreased the ubiquitination of c-Myc. 24 h after transfection with HA-Ub and siFBXW7, QBC-939 cells were incubated in 10 μM MG132 for 12 h. HA beads were used to precipitate HA-interacting proteins and c-Myc antibody was used to detect the ubiquitinated c-Myc. e , f c-Myc inhibitor 10,058-F4( e ) and c-Myc knockdown( f ) decreased the expression of HMGA1 and TRIP13 in pCCA cells. 10,058-F4(10 μM) was used to pre-incubate QBC-939 cells for 12 h. g Luciferase assays revealed that c-Myc promoted the transcription of TRIP13 and HMGA1 of QBC-939 cells. The transcriptional activity of HMGA1 (up) and TRIP13 (bottom) were detected with luciferase assays. ** represents P < 0.01, calculated with T-test. h HMGA1 knockdown rapidly decreased TRIP13 expression, while TRIP13 knockdown attenuated HMGA1 expression 12–24 h later. QBC-939 were transfected with shTRIP13 or shHMGA1 and incubated for 0–96 h. Analyzed data were from three independent experiments, and each subgroup was performed at least in triplicate

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc

doi: 10.1186/s13046-021-01890-1

Figure Lengend Snippet: HMGA1-TRIP13 axis promotes invasion, stemness and EMT in a positive feedback pathway dependent on c-Myc. a , b WB( a ) and qRT-PCR( b ) showed that FBXW7 and TRIP13 knockdown regulated c-Myc expression but had little effect on c-Myc mRNA. c MG132 inhibited the FBXW7-induced c-Myc degradation. QBC-939(left) and FRH-0201(right) were incubated in 10 μM MG132 for 12 h before lysis. d FBXW7 knockdown decreased the ubiquitination of c-Myc. 24 h after transfection with HA-Ub and siFBXW7, QBC-939 cells were incubated in 10 μM MG132 for 12 h. HA beads were used to precipitate HA-interacting proteins and c-Myc antibody was used to detect the ubiquitinated c-Myc. e , f c-Myc inhibitor 10,058-F4( e ) and c-Myc knockdown( f ) decreased the expression of HMGA1 and TRIP13 in pCCA cells. 10,058-F4(10 μM) was used to pre-incubate QBC-939 cells for 12 h. g Luciferase assays revealed that c-Myc promoted the transcription of TRIP13 and HMGA1 of QBC-939 cells. The transcriptional activity of HMGA1 (up) and TRIP13 (bottom) were detected with luciferase assays. ** represents P < 0.01, calculated with T-test. h HMGA1 knockdown rapidly decreased TRIP13 expression, while TRIP13 knockdown attenuated HMGA1 expression 12–24 h later. QBC-939 were transfected with shTRIP13 or shHMGA1 and incubated for 0–96 h. Analyzed data were from three independent experiments, and each subgroup was performed at least in triplicate

Article Snippet: Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ).

Techniques: Quantitative RT-PCR, Knockdown, Expressing, Incubation, Lysis, Ubiquitin Proteomics, Transfection, Luciferase, Activity Assay

The schematic depiction of the positive feedback loop of HMGA1-TRIP13-c-Myc pathway. HMGA1 can induce the transcription and expression of TRIP13 , therefore suppress FBXW7 expression and stabilize c-Myc, and eventually promote pCCA proliferation, migration, invasion, stemness and EMT. In the other side, c-Myc promoted HMGA1 and TRIP13 transcription, forming a positive feedback loop to amplify the effects of HMGA1-TRIP13 axis. Moreover, HMGA1 increased c-Myc expression via upregulating TCF family, which established another positive feedback pathway

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc

doi: 10.1186/s13046-021-01890-1

Figure Lengend Snippet: The schematic depiction of the positive feedback loop of HMGA1-TRIP13-c-Myc pathway. HMGA1 can induce the transcription and expression of TRIP13 , therefore suppress FBXW7 expression and stabilize c-Myc, and eventually promote pCCA proliferation, migration, invasion, stemness and EMT. In the other side, c-Myc promoted HMGA1 and TRIP13 transcription, forming a positive feedback loop to amplify the effects of HMGA1-TRIP13 axis. Moreover, HMGA1 increased c-Myc expression via upregulating TCF family, which established another positive feedback pathway

Article Snippet: Bottom: quantification of bands in the left panel. d Representative images of immunohistochemical staining for low/high expression of HMGA1 in the tissue microarray (top: 100× magnification, scale bar, 200 μm; bottom: 400× magnification, scale bar, 50 μm). e Correlation between HMGA1 expression and clinicopathological features (Chi-square tests). f Kaplan-Meier survival analysis in patients with pCCA with low ( n = 35) and high ( n = 71) HMGA1 expression (cut-off: 77.4). g HMGA1 expression in human cholangiocarcinoma cell lines, gallbladder carcinoma cell lines, and intrahepatic bile duct cell line HiBEpiC. (H) HMGA1 was silenced in QBC939 and overexpressed in FRH0201, and the effects of HMGA1 on pCCA cell proliferation were measured by CCK-8 assays. i effects of HMGA1 on colony formation in QBC939 and FRH0201 cells after knockdown in QBC939 or overexpression in FRH0201. j QBC939 cells with stable HMGA1 knockdown (up) or overexpression (bottom) were subcutaneously injected to nude mice for xenograft model ( n = 6/group). k Tumor volumes in xenografts established using cells infected with lentivirus carrying scrambled shRNA, shHMGA1, empty vector, or GV492-HMGA1. l , m The effects of HMGA1 on migration and invasion were detected with wound-healing assay( l ) and transwell assay( m ) after silencing HMGA1 in QBC939 or overexpressing HMGA1 in FRH0201 cells. n Effects of HMGA1 on stemness was detected by 7-day-sphere formation activity with stable HMGA1 -silencing or HMGA1 -overexpressing QBC939 cells. o , p Effects of HMGA1 on EMT were detected by Western blot after silencing HMGA1 in QBC939( o ) and overexpressing HMGA1 in FRH0201 cells( p ).

Techniques: Expressing, Migration